Delaware is the US’s go-to venue for pharma patent litigation, but there could be trouble ahead
Reset password
Register to access two of our subscriber only articles per month.
Register
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe
Author | Life sciences reporter
[email protected]
@IAM_magazine Bristol Myers Squibb's Henry Hadad on IP and the covid pandemic and why more needs to be done on 101 reform… https://t.co/dp4RDjKBTG Read more
@IAM_magazine After PTAB upholds key patent, Moderna set to face infringement battle over its covid-19 vaccine mRNA-1273:… https://t.co/8kthk3cE58 Read more
@IAM_magazine Chinese tech companies are under pressure like never before in India, and the patent litigation keeps coming… https://t.co/TkwjY68Ywj Read more
@IAM_magazine RT @McDermottLaw: Join Jed Gordon, Head of the Firm’s IP Transactions Practice, & @IAM_magazine @ #IPBCConnect 2020 for the “Proactive IP… Read more
